Literature DB >> 1792926

Changes in antisocial aggressiveness during treatment in a hierarchical therapeutic community. A prospective study of personality changes.

E Ravndal1, P Vaglum.   

Abstract

Thirty-six consecutive substance abusers were examined at intake and after 1 year of residency in a hierarchical therapeutic community using the personality instruments Million Clinical Multiaxial Inventory (MCMI) and Basic Character Inventory. Two antisocial aggressiveness subgroups were identified: a no-increase group (n = 11) that had high intake scores on MCMI antisocial aggression, small changes during the stay and a high dropout rate (45%) as outpatients; and an increase group (n = 25) with lower scores at intake and a low dropout rate (20%). A high level of antisocial aggressiveness at intake was related to dropout in the no-increase group, and a high degree of increase in antisocial aggressiveness was related to dropout in the increase group. The results show the importance of monitoring antisocial aggressiveness during treatment.

Entities:  

Mesh:

Year:  1991        PMID: 1792926     DOI: 10.1111/j.1600-0447.1991.tb03188.x

Source DB:  PubMed          Journal:  Acta Psychiatr Scand        ISSN: 0001-690X            Impact factor:   6.392


  3 in total

1.  For the protection of others. The value of individual autonomy and the safety of others.

Authors:  S Giordano
Journal:  Health Care Anal       Date:  2000

2.  The role of gender differences and other client characteristics in the prevalence of DSM-IV affective disorders among a European therapeutic community population.

Authors:  Joke De Wilde; Eric Broekaert; Yves Rosseel; Philippe Delespaul; Veerle Soyez
Journal:  Psychiatr Q       Date:  2007-03

3.  Aggressive behavior among military veterans in substance use disorder treatment: the roles of posttraumatic stress and impulsivity.

Authors:  Adrienne J Heinz; Kerry Makin-Byrd; Daniel M Blonigen; Patrick Reilly; Christine Timko
Journal:  J Subst Abuse Treat       Date:  2014-11-05
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.